Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries.

EVD vaccination in our hypothetical population was found to be cost-effective from the payer perspective. Our model presents an efficient and reliable approach for conducting economic evaluations of infectious disease interventions as part of an emergency preparedness plan.